ClinicalTrials.Veeva

Menu

RNFL Thickness Measurements Obtained Using SD-OCT and SLP Using GDx Variable Corneal Compensation (Real)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Uveitis

Treatments

Device: SD-OCT and SLP using GDx variable corneal compensation

Study type

Observational

Funder types

Other

Identifiers

NCT03206268
69HCL17_0303

Details and patient eligibility

About

The aim of this study is to evaluate the correlation of retinal nerve fiber layer (RNFL) thickness measured using spectral domain optical coherence tomography (SD-OCT) and scanning laser polarimetry (SLP) in uveitic eyes compared to healthy eyes.

A descriptive, observational, prospective, consecutive, cross-sectional, controlled, mono-center case series was conducted from May to October 2015. Clinical characteristics, best-corrected visual acuity, intra-ocular pressure, RNFL thickness measurement with SD-OCT and SLP using GDx variable corneal compensation (GDx VCC) were performed for each patient. An evaluation of anterior chamber inflammation with laser flare cell meter was also carried out. Correlations between SD-OCT and GDx VCC RNFL measurement were evaluated by linear regression analysis.

Enrollment

54 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age ≥18 years,
  • best-corrected visual acuity better than or equal to 20/40,
  • spherical refraction between -6.00 and +3.00 diopters,
  • no retinal disease or non-glaucomatous neuropathy, and no ophthalmic surgery in the past 6 months.

Exclusion criteria

  • Healthy eye were excluded in case of consecutive and reliable abnormal standard automated perimetry with abnormal Glaucoma Hemifield Test and pattern standard deviation outside 95% of normal limits, and optic nerve damage (asymmetric cup-to-disc ratio ≥ 0.2, rim thinning, notching, excavation, or retinal nerve fiber layer defect).
  • any history of ophthalmic disease.

Trial design

54 participants in 2 patient groups

healthy eyes
Treatment:
Device: SD-OCT and SLP using GDx variable corneal compensation
uveitis eyes
Treatment:
Device: SD-OCT and SLP using GDx variable corneal compensation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems